About EULAR Advocacy
EU Advocacy is a key activity for a European umbrella organisation like the European Alliance of Associations for Rheumatology (EULAR). EULAR aims to reduce the burden of RMDs on individuals and society and to improve the treatment, prevention and rehabilitation of RMDs.To this end, EULAR fosters excellence in education and research in the field of rheumatology. It promotes the translation of research advances into daily care and fights for the recognition of the needs of people with RMDs by the EU institutions through advocacy action. Among others, EU policies play an important role in improving the understanding, prevention and management of health conditions and diseases. Furthermore, EU actions are important in promoting the economic and social inclusion of people with disabilities.
Rheumatic and musculoskeletal diseases: a major burden for the European population
The increasing attention of policy makers and stakeholders on RMDs is due to the enormous and rising burden of these diseases on individuals and societies. RMDs are one of the most prevalent, disabling and costly chronic conditions affecting European countries. Approximately one fourth of the EU population, or around 120 million people, suffer from a RMD at some point in their lives. Recent evidence provided by the eumusc.net project and the Global Burden of Disease Study, among others, show that RMDs are the cause number one of disability in Europe, accounting for about one third of all disabled people. RMDs are also the main occupational disease, representing about 38% of all work-related ill-health. In addition, RMDs are one of the most costly chronic conditions, given the intense use of health care services (for instance, it is the second most common reason for consulting a doctor), as well as the provision of social security (for example, disability and early retirement pensions).
EULAR Advocacy Partnerships
EULAR is committed to partner with organisations and scientific medical societies at a EU and national level towards improving research funding, social policy legislation and quality of care; assisting advocacy actions on the national and international levels around rheumatic and musculoskeletal diseases (RMDs).
A Research Roadmap to transform the lives of people with Rheumatic and Musculoskeletal Diseases.
EULAR Policy Statements
As part of its advocacy activities, EULAR produces and adopts a number of documents and declarations that are used to express EULAR’s position and/or demands on different policy issues.
EU Parliament Interest Group on RMDs
The European Parliament Interest Group on Rheumatic and Musculoskeletal Diseases (RMDs) was created in 2009 on the occasion of World Arthritis Day (12 October) and was re-established during the current parliamentary term (2014-2019).
Links to other organisations
Partnerships that help to increase the knowledge of the organisations involved and the impact they can have on the political stage.
Questions and Answers on RMDs
EULAR description on Rheumatic and Musculoskeletal Diseases (RMDs)